Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00956007 · MORE INFO

Limitations, agreements, and source contact

RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer · Source last updated 2026-01-06

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
other Details
PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
pi Sponsor Employee
false
restriction Type
OTHER
restrictive Agreement
true
limitations And Caveats
description
Due to a lower-than-expected death rate, the statistical design was modified to perform the primary analysis after all randomized patients had a minimum of 5 years of potential follow-up.
point Of Contact
email
seiferheldw@nrgoncology.org
organization
NRG Oncology
phone
2155743208
title
Wendy Seiferheld
Complete source fields
certain Agreement
other Details
PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
pi Sponsor Employee
false
restriction Type
OTHER
restrictive Agreement
true
limitations And Caveats
description
Due to a lower-than-expected death rate, the statistical design was modified to perform the primary analysis after all randomized patients had a minimum of 5 years of potential follow-up.
point Of Contact
email
seiferheldw@nrgoncology.org
organization
NRG Oncology
phone
2155743208
title
Wendy Seiferheld

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice